Researchers have shown that a tiny nanoparticle formulation of saponin, along with an inflammation-promoting molecule called ...

Researchers from MIT and Scripps have unveiled a promising new HIV vaccine approach that generates a powerful immune response ...

The approach employed by the research team could be used against other diseases—including COVID-19 and influenza.

The U.S. has approved the world's only twice-a-year shot to prevent HIV, maker Gilead Sciences announced Wednesday.

The breakthrough double injection won’t be cheap in the US, although scientists argue it could (and should) be.

Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be ...

In the quest to develop an effective HIV vaccine, scientists from Scripps Research have made a significant leap forward. They ...

On May 30, a team of researchers funded by the National Institutes of Health got the word: Funding for their vaccine ...

It's unclear how many people in the US and abroad will get access to the powerful new HIV prevention medication ...

The Trump administration's plan to cut funding for HIV vaccine research comes at a time when the field is making substantial ...